New Nordic Healthbrands AB (SE:NNH)
:NNH
NNH Stock Chart & Stats
kr21.50
kr0.00(0.00%)
At close: 4:00 PM EST
kr21.50
kr0.00(0.00%)
Day’s Range― - ―
52-Week Rangekr13.20 - kr28.00
Previous CloseN/A
Volume5.00K
Average Volume (3M)5.45K
Market Cap
kr109.04M
Enterprise Valuekr128.33M
Total Cash (Recent Filing)kr16.55M
Total Debt (Recent Filing)kr35.84M
Price to Earnings (P/E)17.5
Beta0.19
Next Earnings
Apr 29, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.33
Shares Outstanding6,195,200
10 Day Avg. Volume3,153
30 Day Avg. Volume5,451
Financial Highlights & Ratios
PEG Ratio-0.08
Price to Book (P/B)1.39
Price to Sales (P/S)0.25
P/FCF Ratio18.98
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthA clear step-up in top-line growth, highlighted by +16.9% YoY in 2025, builds a sturdier revenue base that can support durable operating scale. Sustained revenue expansion over months can improve gross absorption of fixed costs and fund targeted investments to stabilize margins and earnings quality.
Improving LeverageA declining debt-to-equity ratio to ~0.35 indicates reduced financial leverage and lower solvency risk, improving the firm's capacity to withstand shocks. Over the medium term this strengthens strategic optionality for reinvestment or opportunistic M&A and lowers refinancing strain in tighter credit cycles.
Improved Cash ConversionFree cash flow equal to roughly 90% of net income in 2025 signals a meaningful improvement in cash conversion and working-capital management that year. If this conversion rate persists, it materially enhances internal funding capacity for capex, reduces reliance on external financing, and supports sustainable operations.
Bears Say
Volatile ProfitabilityA multi-year pattern of losses followed by a slim 2025 net margin (~1.4%) highlights earnings fragility and low margin resilience. Such volatility weakens the predictability of future cash flows and makes strategic planning and reinvestment riskier unless margins reliably re‑normalize above breakeven on a sustained basis.
Inconsistent Cash GenerationA swingy cash profile with multiple years of negative operating and free cash flow undermines the reliability of internal funding. This inconsistency increases the chance of liquidity stress in downturns, complicates capital allocation, and may force dependence on external financing or equity dilution when cash buffers tighten.
Gross Margin PressureA pronounced 2025 gross margin decline suggests material cost pressure, pricing weakness, or adverse mix changes. Given the company’s thin net margin profile, durable gross margin erosion would rapidly compress profitability and cash generation, making recovery contingent on structural cost fixes or restored pricing power.
NNH FAQ
What was New Nordic Healthbrands AB’s price range in the past 12 months?
New Nordic Healthbrands AB lowest stock price was kr13.20 and its highest was kr28.00 in the past 12 months.
What is New Nordic Healthbrands AB’s market cap?
New Nordic Healthbrands AB’s market cap is kr109.04M.
When is New Nordic Healthbrands AB’s upcoming earnings report date?
New Nordic Healthbrands AB’s upcoming earnings report date is Apr 29, 2026 which is in 22 days.
How were New Nordic Healthbrands AB’s earnings last quarter?
New Nordic Healthbrands AB released its earnings results on Feb 28, 2026. The company reported kr0.329 earnings per share for the quarter, beating the consensus estimate of N/A by kr0.329.
Is New Nordic Healthbrands AB overvalued?
According to Wall Street analysts New Nordic Healthbrands AB’s price is currently Overvalued.
Does New Nordic Healthbrands AB pay dividends?
New Nordic Healthbrands AB pays a Annually dividend of kr1.25 which represents an annual dividend yield of N/A. See more information on New Nordic Healthbrands AB dividends here
What is New Nordic Healthbrands AB’s EPS estimate?
New Nordic Healthbrands AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does New Nordic Healthbrands AB have?
New Nordic Healthbrands AB has 6,195,200 shares outstanding.
What happened to New Nordic Healthbrands AB’s price movement after its last earnings report?
New Nordic Healthbrands AB reported an EPS of kr0.329 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.398%.
Which hedge fund is a major shareholder of New Nordic Healthbrands AB?
Currently, no hedge funds are holding shares in SE:NNH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
New Nordic Healthbrands AB
New Nordic Healthbrands AB (publ) develops and markets dietary supplements, natural medicines, and cosmetic products in Sweden. The company provides vitality products for immune system. The company provides balm, repair mask, shampoo, shine serum, chewing gum, face and eye cream, and dietary supplements. It offers its products under Hair Volume, Skin Care, Beauty In & Out, and New Nordic brand names. The company sells its products through pharmacies, department stores, health stores, travel retailers, and beauty shops, as well as through online stores in 41 countries in North America, Canada, Europe, the United States, and internationally. New Nordic Healthbrands AB (publ) was founded in 1990 and is headquartered in Malmö, Sweden.
Technical Analysis
Midsona AB Class B
―
Humble Group AB
―
Skane-moellan AB
―
Cheffelo AB
―
Premium Snacks Nordic AB
―